Veradigm Inc.
Veradigm Inc. (MDRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MDRX · as of Jun 9, 2026
Key Statistics
Explore Veradigm Inc. Data
mdrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 43 · Buy rate: 37.2%
The MDRX analyst consensus is Hold, based on ratings from 43 Wall Street analysts over the past 3 months. The average 12-month price target is $16.17, representing +253.25% upside from the current price of $4.58.
Competitors & Peers
mdrx competitorsMDRX
ARRJF
ELEAF
INRLF
LFTSF
PHCIStock Performance
Full HistoryAbout Veradigm Inc.
Veradigm Inc. is a global healthcare technology enterprise that delivers cutting-edge information technology platforms to a diverse client base, including healthcare providers, health plans (payers), …
what is veradigm inc. · mdrx stock overview · veradigm inc. company profile · who is veradigm inc. ceo · mdrx OTC · veradigm inc. headquarters · veradigm inc. business segments
About Stock Overview & Key Data
Veradigm Inc. (MDRX) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on OTC since Jul 26, 1999. As of the latest trading session, MDRX stock price is $4.58, with a market capitalization of $777.4M. The stock has returned +4.03% over the past 12 months and -0.49% year-to-date.
According to 43 Wall Street analysts, the consensus rating for Veradigm Inc. stock is Hold, with an average 12-month price target of $16.17. In fiscal year 2022, Veradigm Inc. reported revenue of $588.0M and net income of -$86.5M. For detailed data — including Veradigm Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Veradigm Inc. (MDRX) stock price is $4.58. The stock is traded on OTC under the ticker symbol MDRX. The 52-week range is $3.00 – $6.00.